Sign inJoin waitlistJoin the waitlist

KW

Katrina Winsnes

Director, Pediatric Solid Tumor Program · Oregon Health & Science University

Credentials: · ·

History

Oregon Health & Science University
Present

Pediatric Hematology Oncology
Oregon Health & Science University
2015–2018
Pediatrics
University Medical Center
2012–2015
Ross University School of Medicine
2008–2012

Research

Recurrent RET gene fusions in paediatric spindle mesenchymal neoplasms
Case report · Histopathology · 2020 · 55 citations
Delirium in the pediatric hematology, oncology, and bone marrow transplant population
Pediatric Blood & Cancer · 2019 · First of 8 authors · 23 citations
Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy
Histopathology · 2022 · 16 citations

Alanna Church
2 papers
Alyaa Al-Ibraheemi
2 papers
Jessica Davis
2 papers
Katherine Janeway
2 papers
Andrew Artz
1 paper
Archana Shenoy
1 paper
CE
Carl Eriksson
1 paper
CA
Carola Arndt
1 paper
CC
Christopher Corless
1 paper
David Rothstein
1 paper
EE
Elizabeth Eckstrom
1 paper
Erin Rudzinski
1 paper

Clinical trials

A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2029
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2028
Chemotherapy for the Treatment of Patients With Newly Diagnosed Very Low-Risk and Low Risk Fusion Negative Rhabdomyosarcoma
Site PI · Recruiting · Phase 3
Children's Oncology Group
2022–2030